Загрузка...
Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer
Immune checkpoint inhibitors (ICIs), a type of immunotherapy, have become one of the most important therapeutic options for first- and second-line treatment of advanced non-small cell lung cancer (NSCLC). Recent clinical studies have shown that immunotherapy can offer substantial survival benefits t...
Сохранить в:
| Опубликовано в: : | Chin J Cancer Res |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8181868/ https://ncbi.nlm.nih.gov/pubmed/34158740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2021.02.08 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|